Global Business Development and Rights
RIGHTS AND PERMISSIONS
At Oxford University Press (OUP), it is a core part of our objective to encourage the widest possible dissemination of our journal content. We offer a comprehensive suite of licensing services to meet the needs of institutions, pharmaceutical and healthcare companies, and publishers worldwide.
Please see below for more information on the licensing options available:
Permission for reuse or republication of Oxford Journals figures, abstracts, or articles, can be granted for a range of re-uses, including:
- Republication in a book/ journal
- PowerPoint presentation
- Academic course packs
If you wish to obtain permission for these reuses or any other, rights can be obtained by:
The fastest and most efficient way to obtain permission to reuse Oxford Journals content is by using our Rightslink automated permissions system. For details on how to obtain permission through the Rightslink permissions system please click here.
If you are unable to secure the specific permissions you require through our Rightslink permissions system, or if you have any questions or queries about reusing material from Oxford Journals titles, please click here to contact us, providing as much information about your query as possible.
Oxford Open - Open Access
Articles published under our Oxford Open - Open Access model are clearly labeled, and made freely available online immediately upon publication, without subscription barriers to access. In addition, the majority of articles that are made available under Oxford Open, will also allow readers to reuse, republish, and distribute the article in a variety of ways, depending upon the license used. For further detail on Oxford Open and the activities permitted under our Open Access licenses, please click here.
STM Permissions Guidelines & Signatories
A key part of our efforts to minimize the administration that is often involved in permission clearances while ensuring that any re-use of limited amounts of content from our journals is fair and the original source of the material fully attributed. It should be emphasized here that these are just guidelines (for further information please click here).
Rights and Permissions guidelines for Authors
For details of our Publication Rights policies, obtaining third party permission or our general self-archiving policies, please click here.
Reprints are powerful promotional tools, not only at industry-specific exhibitions, conferences and meetings, but also for sales representatives and medical professionals in the field.
Content Ed Net is OUP's current authorised provider for translated article reprints for the pharma industry. For more information on how to obtain translation reprints for your market/ territory, please contact us.
Local Excerpted Editions:
Local Editions provide an excellent opportunity to disseminate important research to healthcare professionals who may not otherwise have access to Oxford Journals content. OUP currently licenses Local Edition rights in more than a dozen territories across the globe.
Publishing partners can select articles of interest to a specific market and distribute sponsored issues in the local language.
For more information on our translation licensing activities, please contact us.
Business Development - Digital Licensing
OUP has an active digital licensing policy across our full range of journals and books. The Business Development group works to establish strategic partnerships and digital licensing relationships with companies all over the world. These activities are heavily focused on maximizing the dissemination, usgae, and discoverability of Oxford content worldwide, while also incubating new business models and routes to market. To this end, the Business Development group licenses material into a wide range of digital platforms, including:
- Online Aggregators
- Mobile technologies
- Discoverability services
- Text Mining databases
- Abstract and Indexing services
For more information or to discuss licensing OUP content, please contact us.
Keeping you Updated
Changes to our list
New launches, new acquisitions, and titles changing frequency